Dr. Ann Taylor is Chief Medical Officer at AstraZeneca. In this role, she is responsible for AstraZeneca’s Patient Safety, Quality Assurance, and Regulatory Policy organizations, and the overall Benefit Risk assessment of our medicines. She is passionate about bringing the patient voice to everything we do.
Prior to joining AstraZeneca in 2018, Dr. Taylor was Vice President and Global Head of the Program Office for the Novartis Institutes for BioMedical Research (NIBR). She also previously served as Global Head, Translational Medicine at NIBR, after having positions of increasing responsibility at Pfizer Global Research and Development.
Dr. Taylor received her M.D. from Harvard Medical School, after receiving her B.A. in Biology magna cum laude from the University of California, San Diego. She completed her internship and residency in Internal Medicine, and her fellowship in Endocrinology and Metabolism at Massachusetts General Hospital, before joining the faculty there. Her research in the Reproductive Endocrine Unit at MGH focused on clinical neuroendocrinology of female reproductive disorders. At MGH, she also led a clinical research training program for students and residents. She has published over 45 journal articles.
Dr. Taylor is passionate about excellence in clinical investigation, diversity in science, and leadership development.